CDK2 (E8J9T) Rabbit Monoclonal Antibody and 4 more items

Cell Signaling Technology Inc. has been awarded a contract by the University of Virginia in Virginia to provide five rabbit monoclonal antibodies for research purposes. The contract, identified as A207_PO-0446159, was awarded on June 6, 2026, with a total contract value of $776.00. The line items comprise specialized research reagents: CDK2 (E8J9T) Rabbit Monoclonal Antibody ($160.20), CDK4 (F8L5F) Rabbit Monoclonal Antibody ($160.20), p21 Waf1/Cip1 (F2C7C) Rabbit Monoclonal Antibody ($144.90), Cyclin D1 (E3P5S) Rabbit Monoclonal Antibody ($151.20), and p16 INK4A (F2T7H) Rabbit Monoclonal Antibody ($160.20). All items are to be delivered to Angela K Best-Campbell at the University of Virginia.

The antibodies specified in this procurement are cell cycle regulation markers commonly used in molecular biology and cancer research applications. This contract represents a routine materials acquisition for the University of Virginia's research operations and reflects the institution's procurement of specialized scientific reagents necessary for ongoing laboratory investigations.